DaVita Inc (DVA) has experienced significant events as per the news reports. Q4 2024 earnings call transcript highlights the company's sales surpassing estimates. Albeit this, the stock fell around 11% upon the announcement of
Warren Buffet reducing his stake, which has now gone down to 45%. The company's mixed earnings have played a part in the stock movements and despite this, DaVita continues to be a recommended stock to buy. An increase in Q4 profit has been announced too. Notable movements in the stock's ownership include Summit Trail Advisors LLC,
Mirae Asset Global Investments Co. Ltd., Empowered Funds LLC, and GHP Investment Advisors Inc. hiking their stakes.
Equitable Trust Co., Tobam and abrdn plc however, have reduced their holdings. DaVita's shares also took a hit due to perceived disappointing 2025 profit forecasts. Yet, the company's focus on enhancing kidney care through advanced AI models, as well as certain significant appointments like Jessica Hergenreter as Chief People Officer and David Maughan as new Chief Operating Officer, suggest continued growth and innovation.
Davita DVA News Analytics from Fri, 13 Sep 2024 07:00:00 GMT to Sat, 15 Feb 2025 17:23:25 GMT -
Rating 3
- Innovation 4
- Information 6
- Rumor -2
